C

Clinica Las Condes | Clinica Las Condes - Academic Direction

Research site

(Unclaimed)

Location

Estoril 450, Las Condes, Santiago, Santiago, Chile

Site insights

Top conditions

Top treatments

Nusinersen

Gemcitabine

Edoxaban

SPD476

Capecitabine

Etrasimod

Lithium

Ocrelizumab

Bevacizumab

Atezolizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 15 total trials

A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease (CULTIVATE)

This is a Phase 2/3 study that comprises 5 substudies designed to evaluate the efficacy, safety, and tolerability of oral etrasimod as therapy in adu...

Enrolling

Crohn's Disease

Drug: Placebo

Drug: Etrasimod

A Study to Learn About the Long-Term Safety of Higher Doses of Nusinersen (BIIB058) Given as Injections to Participants With Spinal Muscular Atrophy (SMA) Who Took Part in an Earlier Nusinersen Trial (ONWARD)

In this study, researchers will learn more about the use of nusinersen (BIIB058) in participants with spinal muscular atrophy (SMA). This study is an...

Active, not recruiting

Muscular Atrophy, Spinal

Drug: Nusinersen